Search results
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
Zacks via Yahoo Finance· 4 days agoSome better-ranked stocks in the broader medical space are DaVita Inc. DVA, Cardinal Health, Inc....
Here's Why You Should Retain Medtronic (MDT) Stock for Now
Zacks via Yahoo Finance· 5 days agoPrice Medtronic PLC price | Medtronic PLC Quote Key Picks Some better-ranked stocks in the broader...
IceCure Medical (ICCM) Submits Final Cryoablation Data to FDA
Zacks· 5 days agoFree Report) recently announced that the company had submitted final data to the FDA requesting...
Revvity's (RVTY) Launch to Boost Pharma-Contract Partner Tie-Up
Zacks via Yahoo Finance· 7 days agoRevvity's (RVTY) latest offering is likely to significantly accelerate the pace of drug innovation,...
Philips (PHG) Agrees to a Consent Decree With DOJ and FDA
Zacks via Yahoo Finance· 7 days agoSome better-ranked stocks in the broader medical space are DaVita Inc. DVA, Cardinal Health, Inc....
Intuitive Surgical (ISRG) Q1 Earnings Beat, Procedures Robust
Zacks via Yahoo Finance· 4 days agoIntuitive Surgical's (ISRG) first-quarter results reflect a healthy demand for procedures. Higher...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 15 hours agoNEWARK, Del, April 22, 2024 (GLOBE NEWSWIRE) -- The peripheral vascular stent market value is expected to rise from US$ 4,267.70 million in 2024 to US$ 8,878.00 million by 2034. This market is analyzed to surge ahead at a CAGR of 7.60% over
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
Zacks· 4 days agoFree Report) recently announced the launch of the cryoSPHERE+ cryoablation probe, which uses innovative insulation technology to reduce freeze times by 25% in comparison with AtriCure’s legacy ...